Medline Inc. (NASDAQ:MDLN) priced its secondary offering of 72,554,594 shares at $37.00 each. Selling stockholders include Blackstone, Hellman & Friedman, and ADIA.
Underwriters have a 30-day option to buy an additional 10,883,189 shares. The offering closes on May 28, 2026.
Medline receives no proceeds from the sale. Goldman Sachs, Morgan Stanley, BofA Securities, and J.P. Morgan lead the offering.












